Unité de Fabrication des Médicaments S.A's latest marketcap:
As of 08/19/2025, Unité de Fabrication des Médicaments S.A's market capitalization has reached $101.46 M. According to our data, Unité de Fabrication des Médicaments S.A is the 24965th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 101.46 M |
| Revenue (ttm) | 51.46 M |
| Net Income (ttm) | 6.75 M |
| Shares Out | 32 M |
| EPS (ttm) | 0.21 |
| Forward PE | 13.58 |
| Ex-Dividend Date | 07/26/2024 |
| Earnings Date | 09/16/2025 |
Unité de Fabrication des Médicaments S.A's yearly market capitalization.
| Date | Market Cap | Market Cap(USD) | Change (%) | Global Rank |
|---|---|---|---|---|
| 08/19/2025 | 291.2 M | $101.46 M | 28.33% | 24965 |
| 12/31/2024 | 228.16 M | $71.6 M | -4.68% | 25502 |
| 12/29/2023 | 239.36 M | $77.96 M | 5.06% | 24743 |
| 12/30/2022 | 227.84 M | $73.26 M | -3.91% | 24289 |
| 12/31/2021 | 237.12 M | $82.34 M | -24% | 24367 |
| 12/31/2020 | 312 M | $115.51 M | 4.06% | 19774 |
| 12/31/2019 | 299.84 M | $107.65 M | 12.89% | 17732 |
| 12/31/2018 | 265.6 M | $88.36 M | 5.73% | 17899 |
| 12/29/2017 | 251.2 M | $102.18 M | -14.12% | 17877 |
| 12/30/2016 | 292.5 M | $126.96 M | 14826 |
Company Profile
About Unité de Fabrication des Médicaments S.A.
Uni té de Fabrication des Médicaments S.A. is a pharmaceutical company specializing in the development, manufacturing, and marketing of generic medicines under the UNIMED brand. Established in 1989, the company operates in Tunisia, Africa, Asia, and Europe.
Key Offerings
- Ophthalmic, ENT, and Inhalation Solutions
- Infusion Solutions
- Injectable Fluids
- Penicillin and Cephalosporin Powders
- Vaigtaine Products (approximately 40 presentations across various therapeutic classes)
Additional Services
The company also manufactures medicines for third-party laboratory principals, expanding its role in the pharmaceutical supply chain.
Headquarters: Sousse, Tunisia
Frequently Asked Questions
-
What is Unité de Fabrication des Médicaments S.A's (BVMT-UMED) current market cap?As of 08/19/2025, Unité de Fabrication des Médicaments S.A (including the parent company, if applicable) has an estimated market capitalization of $101.46 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does Unité de Fabrication des Médicaments S.A (BVMT-UMED) rank globally by market cap?Unité de Fabrication des Médicaments S.A global market capitalization ranking is approximately 24965 as of 08/19/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.